1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
US and European Interventional Oncology Devices Market Assessment for Breast Cancer, Forecast to 2020

US and European Interventional Oncology Devices Market Assessment for Breast Cancer, Forecast to 2020

  • September 2019
  • 177 pages
  • ID: 5821879
  • Format: PDF
  • By Frost & Sullivan

Summary

Table of Contents

The research service provides an overview of the interventional oncology devices market for breast cancer in big five countries in Europe and in the United States. The study provides a four-year forecast from 2016 to 2020.

The unique value of this study is that it provides insights gathered from more than 100 end users, including Interventional radiologists, interventional oncologists, and breast surgeons. The segments include ablation devices (primarily radiofrequency, cryo, and microwave), high-intensity–focused ultrasound (HIFU), and embolization devices, which include microcatheters, balloon catheter, microspheres, radioembolization spheres, PVA particles, embolic coils, chemo-embolization, gelatin sponge, bioabsorbable products, and drug-eluting beads.

Breast cancer surgical treatment has evolved from the days of the radical mastectomy to breast conservation surgery.However, over the last 5 years, there has been a stipulated increase in adoption for percutaneous treatment modalities for breast cancer instead of surgery.

These modalities include cryoablation, radiofrequency ablation, microwave ablation, laser ablation, and ultrasound ablation. There are also the newest kinds of HIFU and embolization techniques that are used to treat tumors with precision. The biggest advantage is that most of these procedures are outpatient procedure and require minimal time for conducting the procedure. These segments are changing the dynamics of cancer therapies. Hospitals and manufacturers are interested in knowing the adoption potential of various products across different applications of cancer such as lung, liver, and breast cancers. This study focuses only on breast cancer. It is interesting to note that breast cancer has adoption of these interventions despite established care treatment paradigm. The biggest drawback and concern for this market is lack of reimbursement and insufficient clinical data to increase the scalability of the adoption of these procedures. However, interestingly, the adoption has been seen in a significant way for select anatomies of cancer, and this likely to drive the growth across all other cancer types too in the short term. This study provides infrastructure details, procedure statistics, revenue forecasts, and competitive analysis across countries. The geographic areas covered in the study include the US, Germany, France, Italy, Spain and the UK. These regions have been on focus primarily because of the increased awareness of benefits of the adoption of these technologies and their ability to spend on new technologies and training for the surgeons to use the same. The base year for the study is 2017 and revenue forecasts have been provided until 2020.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Mucin 1 - Pipeline Review, H2 2019

Mucin 1 - Pipeline Review, H2 2019

  • $ 3500
  • August 2019

Mucin 1 - Pipeline Review, H2 2019SummaryMucin 1 (Breast Carcinoma Associated Antigen DF3 or Episialin or H23AG or Krebs Von Den Lungen 6 or PEMT or Peanut Reactive Urinary Mucin or Polymorphic Epithelial ...

Hormone Receptor (HR)-positive/ Human Epidermal Receptor 2 (HER2)-negative Breast Cancer- Epidemiology Forecast–2028

Hormone Receptor (HR)-positive/ Human Epidermal Receptor 2 (HER2)-negative Breast Cancer- Epidemiology Forecast–2028

  • $ 3250
  • September 2019

‘Hormone Receptor (HR)-positive/ Human Epidermal Receptor 2 (HER2)-negative Breast Cancer- Epidemiology Forecast–2028 report delivers an in-depth understanding of the disease, historical, and forecasted ...

Receptor Tyrosine Protein Kinase ERBB 3 - Pipeline Review, H2 2019

Receptor Tyrosine Protein Kinase ERBB 3 - Pipeline Review, H2 2019

  • $ 3500
  • August 2019

Receptor Tyrosine Protein Kinase ERBB 3 - Pipeline Review, H2 2019SummaryReceptor Tyrosine Protein Kinase ERBB 3 (Proto Oncogene Like Protein c ErbB 3 or Tyrosine Kinase Type Cell Surface Receptor HER3 ...


ref:plp2019

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on